Determination of serum aldosterone by liquid chromatography and tandem mass spectrometry: A liquid-liquid extraction method for the ABSCIEX API-5000 mass spectrometry system

Journal of Clinical Pathology

Volumn 65, Issue 5, 2012, Pages 457-462

  Van Der Gugten, Jessica Grace ^a   Dubland, Joshua ^a   Liu, Hua Fen ^b   Wang, Alex ^b   Joseph, Christine ^a   Holmes, Daniel T ^a,c  

^a ST PAUL S HOSPITAL   (Canada)

^b AB SCIEX   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE 1; ALDOSTERONE 2; ALDOSTERONE DERIVATIVE; UNCLASSIFIED DRUG;

ALDOSTERONE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; HORMONE DETERMINATION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SENSITIVITY ANALYSIS; STANDARD; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ALDOSTERONE; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; HYPERALDOSTERONISM; LIQUID-LIQUID EXTRACTION; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 84862815337     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200564     Document Type: Article

References (28)

1. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008;93:3266-81.
2. Mulatero P, Monticone S, Bertello C, et al. Confirmatory tests in the diagnosis of primary aldosteronism. Horm Metab Res 2010;42:406-10.
3. Nieman LK. Approach to the patient with an adrenal incidentaloma. J Clin Endocrinol Metab 2010;95:4106-13.
4. Gardner D, Shoback D. Greenspan's Basic & Clinical Endocrinology: Eighth Edition. 8th edn. McGraw-Hill Medical, 2007.
5. Cartledge S, Lawson N. Aldosterone and renin measurements. Ann Clin Biochem 2000;37(Pt 3):262-78. (Pubitemid 30242756)
6. Stabler TV, Siegel AL. Chemiluminescence immunoassay of aldosterone in serum. Clin Chem 1991;37:1987-9. (Pubitemid 121000156)
7. Perschel FH, Schemer R, Seiler L, et al. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clin Chem 2004;50:1650-5. (Pubitemid 39121234)
8. Fredline VF, Taylor PJ, Dodds HM, et al. A reference method for the analysis of aldosterone in blood by high-performance liquid chromatography- atmospheric pressure chemical ionization-tandem mass spectrometry. Anal Biochem 1997;252:308-13. (Pubitemid 27449714)
9. Turpeinen U, Hämäläinen E, Stenman UH. Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008;862:113-18. (Pubitemid 351173016)
10. Guo T, Taylor RL, Singh RJ, et al. Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin Chim Acta 2006;372:76-82. (Pubitemid 44286760)
11. Taylor PJ, Cooper DP, Gordon RD, et al. Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry. Clin Chem 2009;55:1155-62.
12. Wernke MJ, Schell JD. Solvents and malignancy. Clin Occup Environ Med 2004;4:513-27, vii. (Pubitemid 39172723)
13. Evaluation of the Linearity of Quantitative Measurement Procedures: A statistical Approach; Approved Guideline CLSI document EP6-A. Wayne, PA, USA: Clinical and Laboratory Standards Institute, 2003:23.
14. Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline. 2nd edn. CLSI document EP5-A2, Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2004;24:1-39.
15. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
16. Jones JC, Carter GD, MacGregor GA. Interference by polar metabolites in a direct radioimmunoassay for plasma aldosterone. Ann Clin Biochem 1981;18:54-9. (Pubitemid 11148820)
17. Koshida H, Miyamori I, Miyazaki R, et al. Falsely elevated plasma aldosterone concentration by direct radioimmunoassay in chronic renal failure. J Lab Clin Med 1989;114:294-300. (Pubitemid 19221263)
18. Passing H, Bablok. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, part I. J Clin Chem Clin Biochem 1983;21:709-20. (Pubitemid 14208512)
19. Martin VI, Edwards CR, Biglieri EG, et al. The development and application of a radioimmunoassay for 18-hydroxy-corticosterone. Steroids 1975;26:591-604.
20. Perrin CW. Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins, 2001.
21. Petersen PH, Stöckl D, Westgard JO, et al. Models for combining random and systematic errors. assumptions and consequences for different models. Clin Chem Lab Med 2001;39:589-95. (Pubitemid 32725742)
22. Westgard Biological Variation Database. http://www.westgard.com/ biodatabase1.htm (accessed 3 Jan 2012).
23. Schirpenbach C, Seiler L, Maser-Gluth C, et al. Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Clin Chem 2006;52:1749-55. (Pubitemid 44330710)
24. Stowasser M, Gordon RD. Aldosterone assays: an urgent need for improvement. Clin Chem 2006;52:1640-2. (Pubitemid 44330694)
25. Raffaelli A, Saba A. Atmospheric pressure photoionization mass spectrometry. Mass Spectrom Rev 2003;22:318-31.
26. Trainer PJ, Barth J, Sturgeon C, et al. Consensus statement on the standardisation of GH assays. Eur J Endocrinol 2006;155:1-2. (Pubitemid 44103367)
27. National glycohemoglobin standardization project. http://www.ngsp.org/ (accessed 3 Jan 2012).
28. Rosner W, Vesper H; On behalf of The Endocrine Society the endorsing organizations. Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metab 2010;95:4542-8.